Back to results
US 2004/0203155 A1Published application
Methods for transfecting T cells
AssigneesThe United States of America as represented by the Secretary of the Navy, The Regents of the University of Michigan
InventorsCarl H. June, Craig B. Thompson, Suil Kim
Life of this patent
Estimating the term…
Abstract
A method for transfecting T cells with a nucleic acid molecule comprising a gene such that the gene is expressed in the T cells is described. The T cells are stimulated and proliferating prior to introduction of the nucleic acid molecule.
Claims38
1-21. (Cancelled)
A method for increasing the expression of an exogenous nucleic acid molecule in T cells, comprising
- (a) contacting the T cells in vitro with at least one stimulatory agent;
- and
- (b) introducing the exogenous nucleic acid molecule into the T cells from step (a) in vitro, less than about 24 hours after contacting of said T cells,
- such that the expression of the exogenous nucleic acid molecule is increased in the T cells;
- and
- wherein said exogenous nucleic acid molecule is introduced into the T cells using a viral vector.
3 more elements
A method for increasing the expression of an exogenous nucleic acid molecule in T cells, comprising:
- (a) contacting the T cells in vitro with at least one stimulatory agent, wherein the at least one stimulatory agent is a combination of a first agent which provides a primary activation signal to the T cells and a second agent which provides a costimulatory signal to the T cells;
- and
- (b) introducing an exogenous nucleic acid molecule into the T cells from step (a) in vitro less than about 24 hours after contacting of said T cells,
- such that the expression of the exogenous nucleic acid molecule is increased in the T cells;
- and
- wherein said exogenous nucleic acid molecule is introduced into the T cells using a viral vector.
3 more elements
Dependencies are inferred from the claim text.